查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564642

多模態成像美國市場評估：依技術、應用、最終用戶、地區、機會、預測（2017-2031）

United States Multimodal Imaging Market Assessment, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 120 Pages | 商品交期: 3-5個工作天內

價格

美國多模態成像市場規模預計將從2023年的16.5億美元增至2031年的25.3億美元，在2024-2031年預測期內年複合成長率預計為 5.50%。由於多種關鍵因素，包括先進成像解決方案的日益採用、有利的償付方案以及新產品的批准，美國多模態成像行業快速成長。

多模態成像結合了 PET/CT、PET/MRI 和 SPECT/CT 等診斷方式，可提供心臟、神經系統、腫瘤等的全面解剖、功能和分子洞察。和診斷的準確性。更快的資料處理、更高解析度的傳感器和使用人工智慧的圖像處理等技術改進大幅提高了這些系統的效率。在臨床研究和個人化醫療中的越來越多的使用也推動了市場的擴張。對醫學研究和基礎設施的大量投資以及支持性的法律框架進一步支持了先進成像技術的採用。惡性腫瘤和慢性病的盛行率不斷增加，進一步增加了對準確診斷設備的需求。

此外，隨著更緊湊的行動系統的發展，這些診斷工具在偏遠和服務不足的地區變得越來越廣泛。例如，2023年5月，在FDA批准其用於12歲以上患者後，Cincinnati Children's Hospital Medical Centre推出了氙氣MRI（XENOVIEW），這是一種用於診斷患者的新型（Xe）氣體混合物。

本報告研究和分析了美國多模態成像市場，提供市場規模和預測、市場動態以及主要參與者的狀況。

目錄

第1章 專案範圍與定義

第2章 研究方法

第3章 執行摘要

第4章 美國多模態成像市場前景（2017-2031）

  • 市場規模分析與預測
    • 金額
    • 數量
  • 市佔率分析與預測
    • 依技術
    • 依用途
    • 依最終用戶
    • 依地區
    • 市佔率分析：依公司劃分（金額）（前5名公司及其他 -2023年）
  • 市場地圖分析（2023年）
    • 依技術
    • 依用途
    • 依最終用戶
    • 依地區

第5章 供需分析

第6章 進出口分析

第7章 價值鏈分析

第8章 波特五力分析

第9章 PESTLE分析

第10章 價格分析

第11章 市場動態

  • 市場驅動因素
  • 市場挑戰

第12章 市場趨勢與發展

第13章 監理架構與創新

  • 監理機關的核准

第14章 專利狀況

第15章 個案研究

第16章 競爭態勢

  • 前5名市場領導者的競爭矩陣
  • 前5名的公司的SWOT 分析
  • 市場前10名企業主要企業狀況
    • GE Healthcare Technologies Inc.
    • Canon Medical Systems Corporation
    • Koninklijke Philips N.V.
    • Siemens Healthineers AG
    • Carl Zeiss AG
    • Mediso Ltd.
    • Neusoft Medical Systems Co. Ltd.
    • Bruker Corporation
    • Spectrum Dynamics Medical Group Limited
    • MILabs B.V.

第17章 策略建議

第18章 關於本公司，免責聲明

Product Code: MX12004

United States multimodal imaging market is projected to witness a CAGR of 5.50% during the forecast period 2024-2031, growing from USD 1.65 billion in 2023 to USD 2.53 billion in 2031. Due to several important factors, such as the growing adoption of advanced imaging solutions, favorable reimbursement scenarios, and new product approvals, the multimodal imaging industry in the United States is growing at a faster pace.

The combination of diagnostic methods such as PET/CT, PET/MRI, and SPECT/CT, multimodal imaging provides comprehensive anatomical, functional, and molecular insights that have the potential to improve treatment planning and diagnostic accuracy in fields like cardiology, neurology, and oncology. Improvements in technology, such as faster data processing, higher resolution sensors, and AI-driven imagery, are greatly increasing the effectiveness of these systems. Growing applications in clinical research and personalized medicine also fuel market expansion. The adoption of advanced imaging technologies is further aided by significant investments in healthcare research and infrastructure as well as by supportive legislative frameworks. The rising incidence of malignancies and chronic illnesses further fuels the need for accurate diagnostic instruments.

Furthermore, these diagnostic tools are now more widely available, even in isolated or underserved areas, due to the development of portable systems that are much more compact. For instance, in May 2023, following its FDA approval for use in patients of 12 years age and older, Cincinnati Children's Hospital Medical Centre became the first hospital in the United States to diagnose a patient using xenon MRI, or XENOVIEW, a novel xenon (Xe) gas blend that allows a safe and detailed view of lung ventilation.

Market Growth Due to Technological Advancements

Technological developments are driving the multimodal imaging industry in the United States. Artificial intelligence (AI) and machine learning (ML) algorithms are examples of modern advances that improve picture quality, processing, and interpretation, leading to more precise and effective imaging systems. Hybrid PET/MRI and PET/CT are examples of advanced imaging techniques that combine multiple modalities to deliver rich anatomical and functional information in a single session, providing maximum possible insights. More accurate diagnoses and better patient results are also a result of advancements in imaging hardware, such as faster data processing speeds and higher-resolution sensors. The amalgamation of cloud computing with telemedicine additionally expedites distant consultations and data exchange, hence expanding the reach and practicality of multimodal imaging.

Furthermore, growing investments in research and development drive continuous innovation, creating new applications and expanding market potential. Collectively, these technological advancements enhance diagnostic capabilities and streamline workflows, fueling the expansion of the multimodal imaging market in the United States. For instance, in November 2022, Spectrum Dynamics Medical Group Limited unveiled VERITON-CT 400 Series of SPECT/CT platform under their digital nuclear medicine imaging portfolio. The systems employ solid-state detector technology, allowing imaging applications for the entire body, brain, heart, and other parts of the body.

Rising Application of Multimodal Imaging Boosts the Market Growth

The United States multimodal imaging market is expanding at a substantial rate because of the growing use of multimodal imaging equipment. Multimodal imaging combines anatomical, functional, and molecular data to produce comprehensive diagnostic information by integrating many imaging techniques, including PET/CT, PET/MRI, and SPECT/CT. This integration improves treatment planning and diagnostic accuracy, especially in oncology, neurology, and cardiology, where precise imaging is essential. Multimodal imaging has a significant market potential due to its increasing application in clinical research and personalized medicine, which allows more precise disease monitoring and individualized treatment plans. Advances in imaging technology have also increased the affordability and accessibility of these systems, leading to a rise in their use in clinical and research contexts. As healthcare providers seek to improve patient outcomes and streamline diagnostics, the demand for sophisticated multimodal imaging solutions continues to rise.

Consequently, the expanding range of applications and benefits drive market growth, reflecting a broader trend towards integrated and precise diagnostic imaging. For instance, the FDA's approval of Siemens Healthineers AG's Biograph Vision.X PET/CT scanner, received in November 2023, serves as a prime example of the growing use of multimodal imaging. The United States multimodal imaging market is expanding due to the increased need for integrated imaging solutions, which is seen in this advanced system that combines PET and CT for enhanced cancer diagnosis.

Promising Growth of PET/MRI Segment in the United States Multimodal Imaging Market

The United States multimodal imaging market is growing at a substantial rate due to the dominance of the PET/MRI segment. PET/MRI combines high-resolution anatomical imaging of magnetic resonance imaging (MRI) with sophisticated functional imaging capabilities of positron emission tomography (PET). This combination offers a thorough research and study of both structural and metabolic problems, improving therapy planning and diagnostic accuracy, particularly in the fields of neurology and oncology. The PET/MRI technology is gaining traction among healthcare professionals due to its capability to produce detailed images with less radiation exposure when compared to traditional PET/CT scans. Adoption of PET/MRI systems is also fuelled by the quick advances in technology, which include faster data capture and better image resolution.

As medical professionals and researchers increasingly recognize the value of PET/MRI in delivering superior diagnostic insights and improving patient outcomes, the segment's prominence grows, contributing to the overall expansion of the multimodal imaging market in the United States. For instance, the FDA granted 510(k) clearance for FUJIFILM Healthcare Americas Corporation's new 1.5 Tesla magnetic resonance imaging (MRI) system, the ECHELON Synergy, in August 2023.

Neurology Segment Dominates Multimodal Imaging Market

Multimodal imaging technology is capable of obtaining fine-grained images of nervous systems, thus can be used to diagnose a number of neurological conditions, ranging from stroke, traumatic brain injury, brain and spinal cord tumors, inflammation, infection, vascular abnormalities, brain damage connected to epilepsy to abnormally formed brain regions, and other neurodegenerative illnesses. Due to the growing use of multimodal imaging in the diagnosis of neurological diseases and the development of sophisticated equipment for neurology, the neurology segment of the market is anticipated to rise significantly. Additionally, it is anticipated that the rise in neurological conditions like dementia and Alzheimer's disease will increase demand for MRI machines in the United States, which will probably support the market's expansion throughout the projection period. For example, the Alzheimer's Disease Facts and Figures 2023 study estimates that 6.7 million Americans 65 years of age and older will receive an Alzheimer's dementia diagnosis in 2023. Furthermore, it is anticipated that by 2050, there would be 12.7 million of them living in the United States.

Future Market Scenario (2024-2031F)

The main factors contributing to the anticipated growth of the multimodal imaging systems market are the rising numbers of chronic diseases, increasing population and awareness, and thus, the rising need to conduct diagnostic tests. However, the growing need for precision medicine to maintain a healthy population is also going to fuel market growth in the future. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. Government policies and policies made by welfare bodies are also greatly fueling the market expansion.

For instance, in October 2023, Koninklijke Philips N.V. (Philips) announced its collaboration with Quibim, S.L. (Quibim) to introduce advanced AI-driven imaging software aimed at prostate cancer detection. By combining Philips' innovative AI-enhanced MR imaging software with Quibim's AI-powered image analysis software, healthcare providers can expedite and simplify prostate cancer diagnosis and care.

Key Players Landscape and Outlook

Companies operating in the market are complying with new strategic initiatives regarding the launches of newly developed multimodal imaging techniques, to help researchers and to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

For example, in June 2024, Positron Corporation, a manufacturer of advanced molecular imaging medical device has entered a business cooperation agreement with Shenyang Intelligent Neuclear Medical Technology Co. Through this cooperation agreement, Positron Corporation has entered US market and expanded sale of its FDA approved NeuSight PET-CT 64 slice scanner.

Moreover, in July 2022, Canon Medical Systems USA Inc. has acquired NXC Imaging, Inc., a diagnostic imaging equipment distributor and service. This acquisition has helped Canon to expand its penetration of sales and services in the Upper Midwest region.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. United States Multimodal Imaging Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Technology
      • 4.2.1.1. PET/CT Systems
      • 4.2.1.2. SPECT/CT Systems
      • 4.2.1.3. PET/MR Systems
      • 4.2.1.4. OCT/FM Systems
      • 4.2.1.5. Others
    • 4.2.2. By Application
      • 4.2.2.1. Cardiology
      • 4.2.2.2. Oncology
      • 4.2.2.3. Neurology
      • 4.2.2.4. Orthopedic
      • 4.2.2.5. Others
    • 4.2.3. By End-user
      • 4.2.3.1. Hospitals
      • 4.2.3.2. Diagnostic and Imaging Centers
      • 4.2.3.3. Research Institutes
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. Northeast
      • 4.2.4.2. Midwest
      • 4.2.4.3. West
      • 4.2.4.4. South
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Technology
    • 4.3.2. By Application
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

  • 11.1. Market Drivers
  • 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

  • 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

  • 16.1. Competition Matrix of Top 5 Market Leaders
  • 16.2. SWOT Analysis for Top 5 Players
  • 16.3. Key Players Landscape for Top 10 Market Players*
    • 16.3.1. GE Healthcare Technologies Inc.
      • 16.3.1.1. Company Details
      • 16.3.1.2. Key Management Personnel
      • 16.3.1.3. Products and Services
      • 16.3.1.4. Financials (As Reported)
      • 16.3.1.5. Key Market Focus and Geographical Presence
      • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 16.3.2. Canon Medical Systems Corporation
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Siemens Healthineers AG
    • 16.3.5. Carl Zeiss AG
    • 16.3.6. Mediso Ltd.
    • 16.3.7. Neusoft Medical Systems Co. Ltd.
    • 16.3.8. Bruker Corporation
    • 16.3.9. Spectrum Dynamics Medical Group Limited
    • 16.3.10. MILabs B.V.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. United States Multimodal Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. United States Multimodal Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. United States Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 4. United States Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 5. United States Multimodal Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 6. United States Multimodal Imaging Market Share (%), By Region, 2017-2031F
  • Figure 7. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 8. By Application Size Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 9. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 10. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023